Who
Thomas C. Freyman
Director
Company insider
Files Form 4 as: Director, AbbVie; Director, Tenneco; Director, Hanger; Director, Allergan; Executive Vice President, Abbott Laboratories.
In numbers
- Trades disclosed
- 287
- Buys
- 4
- Sells
- 13
- Bought
- $721K
- Sold
- $7.0M
- Companies
- 5
- Companies where not an officer
- 4
- First trade
- 30 Jan 2006
- Last trade
- 8 May 2026
- Last filed
- 12 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month. 1 lines have no legible date and are left out.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 May 2026filed 12 May 2026 | ABBV AbbViePharmaceuticals | SEC FORM 4 Code A | —1,118 at $0.00 | filing |
| 8 May 2026filed 12 May 2026 | ABBV AbbViePharmaceuticals | SEC FORM 4 Code A | —1,118 at $0.00 | filing |
| 9 May 2025filed 13 May 2025 | ABBV AbbViePharmaceuticals | SEC FORM 4 Code A | —1,203 at $0.00 | filing |
| 3 May 2024filed 7 May 2024 | ABBV AbbViePharmaceuticals | SEC FORM 4 Code A | —1,322 at $0.00 | filing |
| 5 May 2023filed 9 May 2023 | ABBV AbbViePharmaceuticals | SEC FORM 4 Code A | —1,450 at $0.00 | filing |
| 17 Nov 2022filed 21 Nov 2022 | Tenneco | SEC FORM 4 Code D | $1.9M93,892 at $20.00 | filing |
| 3 Oct 2022filed 4 Oct 2022 | Hanger | SEC FORM 4 Code D | $817K43,561 at $18.75 | filing |
| 2 Jun 2022filed 3 Jun 2022 | Hanger | SEC FORM 4 Code A | —9,911 at $0.00 | filing |
| 6 May 2022filed 9 May 2022 | ABBV AbbViePharmaceuticals | SEC FORM 4 Code A | —1,421 at $0.00 | filing |
| 1 Feb 2022filed 2 Feb 2022 | Tenneco | SEC FORM 4 Code A | —15,110 at $0.00 | filing |
| 26 May 2021filed 27 May 2021 | Hanger | SEC FORM 4 Code A | —5,484 at $0.00 | filing |
| 7 May 2021filed 11 May 2021 | ABBV AbbViePharmaceuticals | SEC FORM 4 Code A | —1,681 at $0.00 | filing |
| 2 Feb 2021filed 4 Feb 2021 | Tenneco | SEC FORM 4 Code A | —10,850 at $0.00 | filing |
| 7 Aug 2020filed 7 Aug 2020 | Tenneco | SEC FORM 4 Bought | $231K30,000 at $7.70 | filing |
| 20 May 2020filed 21 May 2020 | Hanger | SEC FORM 4 Code A | —8,178 at $0.00 | filing |
| 8 May 2020filed 22 May 2020 | ABBV AbbViePharmaceuticals | SEC FORM 4 Code A | —2,583 | filing |
| 8 May 2020filed 22 May 2020 | ABBV AbbViePharmaceuticals | SEC FORM 4 Code A | —2,333 | filing |
| 8 May 2020filed 12 May 2020 | ABBV AbbViePharmaceuticals | SEC FORM 4 Code A | —2,583 | filing |
| 8 May 2020filed 12 May 2020 | ABBV AbbViePharmaceuticals | SEC FORM 4 Code A | —2,333 | filing |
| 8 May 2020filed 11 May 2020 | Allergan | SEC FORM 4 Code D | —2,983 at $0.00 | filing |
News
Abbott Laboratories (NYSE:ABT) Given "Buy" Rating at TD CowenABT · dailypolitical.com · 16 Oct 2026Abbott Laboratories is More than a Dividend Stock. Here's Why.ABT · insidermonkey.com · 11 Oct 2026Barclays Initiates Coverage on Abbott Laboratories (NYSE:ABT)ABT · themarketsdaily.com · 9 Oct 2026
0 headlines in the last 90 days name Thomas C. Freyman; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.